Funded Tech Companies
PRISM BioLab
Operating out of Fujisawa, Kanagawa, PRISM BioLab is venture-backed, with investment from Eli Lilly and Company.
Company Overview
Company Name
PRISM BioLab
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2-26-1, Muraoka-Higashi
Fujisawa, Kanagawa, 251-8555
Japan
Fujisawa, Kanagawa, 251-8555
Japan
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
PRISM BioLab was founded in 2006 by a group of scientists dedicated to creating new drugs based on their technology of peptide mimetic small molecules. More than ten years of research and development has resulted in the clinical pipelines and numerous discoveries of potential seed compounds. Through its PepMetics® Platform, PRISM has established a proven technology which has already generated successful compounds for what were previously thought to be "undruggable targets".
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/26/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dai Takehara
Chief Financial Officer
Michihiro Maeda
Chief Technical Officer
Tatsuya Toma
VP - R & D
Hyi-Man Park
Company Investors
- Eli Lilly and Company
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs